Press releases are posted on Independent.com as a free community service.

Intellia Therapeutics (NTLA) announced the first patient has been dosed in MAGNITUDE-2, a global, pivotal Phase 3 trial of nexiguran ...

de Crescenzo steps into a company that has seen significant growth and transformation under Hummel’s leadership. Since 2017, Hummel has strengthened TRIMEDX’s position as an industry leader in ...